Internal Medicine, Hematology & Oncology · Paramus, NJ
NPI
1538491212
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1 Valley Health Plz
Paramus, NJ, 07652
Phone (201) 634-5353
Groups this clinician bills Medicare through
Medicare paid, 2024
$157K
3,152 services
Medicare patients, 2024
600
Average age 77
Drug cost, 2024
$8.6M
1,749 prescriptions
Company payments, 2025
$1,785
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jason Suh was code 36415 (venipuncture blood collection), 812 times for 360 patients. In total Jason Suh billed 3,152 services in 37 codes, and Medicare paid $157K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 812 | 360 | $8.57 | $6,955 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 763 | 394 | $14.61 | $11K |
| 99213 Office E&M - Established | Office | 539 | 328 | $73.00 | $39K |
| 99214 Office E&M - Established | Office | 367 | 196 | $106.05 | $39K |
| 99215 Office E&M - Established | Office | 121 | 79 | $159.61 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 106 | 59 | $71.40 | $7,568 |
| 99231 Hospital E&M - Subsequent | Facility | 65 | 47 | $42.66 | $2,773 |
| 99222 Hospital E&M - Initial | Facility | 60 | 58 | $117.56 | $7,054 |
| 99204 Office E&M - New | Office | 39 | 39 | $141.33 | $5,512 |
| 99233 Hospital E&M - Subsequent | Facility | 32 | 25 | $102.31 | $3,274 |
| G0008 Administration of influenza virus vaccine | Office | 23 | 23 | $28.84 | $663 |
| 90662 Vaccine Product | Office | 22 | 22 | $77.19 | $1,698 |
| 99205 Office E&M - New | Office | 21 | 21 | $174.14 | $3,657 |
| 38222 Other Organ Systems | Office | 15 | 15 | $148.21 | $2,223 |
| 99221 Hospital E&M - Initial | Facility | 13 | 13 | $68.96 | $896 |
By year: 2022 $137K for 2,413 services; 2023 $145K for 2,424 services; 2024 $157K for 3,152 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 812 | 360 | $8.57 | $6,955 |
Medicare prescription drug claims, 2024
In 2024, the drug Jason Suh prescribed most often to Medicare patients was Acyclovir, with 184 prescriptions and refills. In total Jason Suh wrote 1,749 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 184 | 386 | 55 | $2,274 |
| Lenalidomide Generic | 124 | 124 | 18 | $1.9M |
| Xarelto Rivaroxaban | 108 | 218 | 26 | $117K |
| Hydroxyurea Generic | 93 | 244 | 27 | $2,663 |
| Venclexta Venetoclax | 88 | 89 | 14 | $819K |
| Brukinsa Zanubrutinib | 67 | 67 | Under 11 | $738K |
| Revlimid Lenalidomide | 66 | 66 | 14 | $1.3M |
| Jakafi Ruxolitinib Phosphate | 65 | 65 | Under 11 | $711K |
| Pomalyst Pomalidomide | 61 | 61 | Under 11 | $1.2M |
| Prednisone Generic | 60 | 77 | 21 | $225 |
| Eliquis Apixaban | 53 | 94 | 13 | $53K |
| Ninlaro Ixazomib Citrate | 49 | 49 | Under 11 | $658K |
| Dexamethasone Generic | 40 | 54 | 13 | $432 |
| Ondansetron Odt Ondansetron | 29 | 29 | 25 | $322 |
| Allopurinol Generic | 27 | 37 | 14 | $159 |
Brand drugs: - claims; generic drugs: 1,061 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jason Suh $1,785 ($1,785 in general payments such as food, travel and fees) from 7 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $1,563.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.